Form 4: Cytek Biosciences Executive Receives Stock Grant
Insider Transaction (Form 4)
Ilan Feuchtwang, Chief Legal Officer, Secretary of Cytek Biosciences, Inc., reported multiple transactions in common stock on August 10, 2026.
Summary
- Grant/award: acquired 241,416 Restricted Stock Units on August 10, 2026; holds 241,416 after (Direct).
- Grant/award: acquired 127,118 Employee Stock Option (right to buy) on August 10, 2026; holds 127,118 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ilan Feuchtwang — Officer (Chief Legal Officer, Secretary)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-10 | Grant/award | Restricted Stock Units | 241,416 | — | — | 241,416 |
| 2026-08-10 | Grant/award | Employee Stock Option (right to buy) | 127,118 | — | — | 127,118 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-10 | Grant/award (241,416 shares) |
| 2026-08-10 | Grant/award (127,118 shares) |
Keywords
insider transaction, Form 4, CTKB, Cytek Biosciences, Inc., neutral, Ilan Feuchtwang
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.